DUBLIN–(BUSINESS WIRE)–The “Hemostasis Diagnostics: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Hemostasis Diagnostics Market to Reach $2.7 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Hemostasis Diagnostics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Prothrombin Test Time (PT), one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the D Dimer segment is readjusted to a revised 5.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $535.9 Million, While China is Forecast to Grow at 8.5% CAGR
The Hemostasis Diagnostics market in the U.S. is estimated at US$535.9 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$561.5 Million by the year 2027 trailing a CAGR of 8.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$354.1 Million by the year 2027.
Fibrinogen Segment to Record 4.9% CAGR
In the global Fibrinogen segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$250.4 Million in the year 2020 will reach a projected size of US$339.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 6% CAGR through the analysis period.
Select Competitors (Total 46 Featured) –
- Abbott Laboratories
- Alere, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Grifols SA
- Instrumentation Laboratory
- Nihon Kohden Corporation
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Hemostasis Diagnostics – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
- Abbott Laboratories
- Alere, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Grifols SA
- Instrumentation Laboratory
- Nihon Kohden Corporation
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/2hhe61
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900